Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery

European Journal of Pharmaceutical Sciences

Volumn 62, Issue , 2014, Pages 243-250

  Unsoy, Gozde ^a   Khodadust, Rouhollah ^a   Yalcin, Serap ^b   Mutlu, Pelin ^a   Gunduz, Ufuk ^a  

^a MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

^b AHI EVRAN UNIVERSITY   (Turkey)

Author keywords

Chitosan; Doxorubicin; Magnetic nanoparticles; Targeted drug delivery

Indexed keywords

CHITOSAN; DOXORUBICIN; MAGNETIC NANOPARTICLE; ANTINEOPLASTIC ANTIBIOTIC; MAGNETITE NANOPARTICLE;

ARTICLE; BREAST CANCER; CANCER RESISTANCE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; INTERNALIZATION; MAGNETIC FIELD; MCF 7 CELL LINE; MOLECULAR STABILITY; PARTICLE SIZE; PH; PRIORITY JOURNAL; SYNTHESIS; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; DRUG STABILITY;

ANTIBIOTICS, ANTINEOPLASTIC; CELL SURVIVAL; CHITOSAN; DOXORUBICIN; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; DRUG STABILITY; HUMANS; HYDROGEN-ION CONCENTRATION; MAGNETITE NANOPARTICLES; MCF-7 CELLS;

EID: 84903604180     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2014.05.021     Document Type: Article

References (40)

1. S.A. Agnihotri, N.N. Mallikarjuna, and T.M. Aminabhavi Recent advances on chitosan-based micro- and nanoparticles in drug delivery J. Control. Release 100 2004 5 28 (Pubitemid 39445982)
2. F. Andrade, F. Antunes, A.N.S. da Silva, J. das Neves, D. Ferreira, and B. Sarmento Chitosan formulations as carriers for therapeutic proteins Curr. Drug Discov. Technol. 8 2011 157 172
3. R.S.T. AydIn, and M. Pulat 5-Fluorouracil encapsulated chitosan nanoparticles for pH-stimulated drug delivery: evaluation of controlled release kinetics J. Nanomater. 313961 2012 1 10
4. J. Berger, M. Reist, J.M. Mayer, O. Felt, N.A. Peppas, and R. Gurny Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications Eur. J. Pharm. Biopharm. 57 1 2004 19 34 (Pubitemid 38058801)
5. S.R. Bhattarai, R.B. Kc, S.Y. Kim, M. Sharma, M.S. Khil, P.H. Hwang, G.H. Chung, and H.Y. Kim N-hexanoyl chitosan stabilized magnetic nanoparticles: implication for cellular labeling and magnetic resonance imaging J. Nanobiotechnol. 6 2008 1
6. S. Bisht, and M. Amarnath Dextran-doxorubicin/chitosan nanoparticles for solid tumor therapy Wiley Interdisciplin. Rev.: Nanomed. Nanobiotechnol. 1 4 2009 415 425
7. M. Dash, F. Chiellini, R.M. Ottenbrite, and E. Chiellini Chitosan: a versatile semi-synthetic polymer in biomedical applications Prog. Polym. Sci. 36 2011 981 1014
8. P. Decuzzi, and M. Ferrari The role of specific and non-specific interactions in receptor-mediated endocytosis of nanoparticles Biomaterials 28 2007 2915 2922 (Pubitemid 46505030)
9. V. Dodane, and V.D. Vilivalam Pharmaceutical applications of chitosan Pharm. Sci. Technol. Today 1 1998 246 253 (Pubitemid 28439296)
10. Dönmez, Y., 2010. Reversal of multidrug resistance by small interfering RNAs (siRNA) in Doxorubicin resistant MCF-7 breast cancer cells. M.Sc. Thesis METU, Ankara, Turkey.
11. K. Engin, D.B. Leeper, J.R. Cater, A.J. Thistlethwaite, L. Tupchong, and J.D. McFarlane Extracellular pH distribution in human tumors Int. J. Hyperth. 11 1995 211 216
12. V. Estrella, T. Chen, M. Lloyd, J. Wojtkowiak, H.H. Cornnell, A.I. Hashim, K. Bailey, Y. Balagurunatham, J.M. Rothberg, B.F. Sloane, J. Johnson, R.A. Gatenby, and R.J. Gillies Acidity generated by the tumor microenvironment drives local invasion Cancer Res. 73 2013 1524 1535
13. E.R. Gillies, and J.M. Fréchet PH-responsive copolymer assemblies for controlled release of Doxorubicin Bioconjug. Chem. 16 2005 361 368 (Pubitemid 40388212)
14. A. Grenha Chitosan nanoparticles: a survey of preparation methods J. Drug Target. 20 2012 291 300
15. A.K. Gupta, R.R. Naregalkar, V.D. Vaidya, and M. Gupta Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications Nanomedicine 2 2007 23 39 (Pubitemid 46845774)
16. M.D. Kars, O.D. Iseri, U. Gunduz, A.U. Ural, F. Arpaci, and J. Molnar Development of rational in vitro models for drug resistance in breast cancer and modulation of MDR by selected compounds Anticancer Res. 26 2006 4559 4568 (Pubitemid 46031531)
17. D. Kavaz, S. Odabas, M. Demirbilek, E.Ö. Güven, and E.B. Denkbaş Bleomycin loaded magnetic chitosan nanoparticles as multifunctional nanocarriers J. Bioactive Compatib. Polym. 25 2010 305 318
18. S. Kayal, and R.V. Ramanujan Doxorubicin loaded PVA coated iron oxide nanoparticles for targeted drug delivery Mater. Sci. Eng., C 30 2010 484 490
19. R. Khodadust, P. Mutlu, S. Yalcin, G. Unsoy, and U. Gunduz Doxorubicin loading, release, and stability of polyamidoamine dendrimer-coated magnetic nanoparticles J. Pharm. Sci. 102.6 2013 1825 1835
20. E.K. Lim, Y.M. Huh, J. Yang, K. Lee, J.S. Suh, and S. Haam PH-triggered drug-releasing magnetic nanoparticles for cancer therapy guided by molecular imaging by MRI Adv. Mater. 23 2011 2436 2442
21. Z. Liu, Y. Jiao, Y. Wang, C. Zhou, and Z. Zhang Polysaccharides-based nanoparticles as drug delivery systems Adv. Drug Deliv. Rev. 60 2008 1650 1662
22. A. Longhi, S. Ferrari, G. Bacci, and S. Specchia Long-term follow-up of patients with doxorubicin-induced cardiac toxicity after chemotherapy for osteosarcoma Anticancer Drugs 18 2007 737 744 (Pubitemid 47343670)
23. H. Maeda The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting Adv. Enzyme Regul. 41 2001 189 207
24. I. Mellman, R. Fuchs, and A. Helenius Acidification of the endocytic and exocytic pathways Annu. Rev. Biochem. 55 1986 773 800
25. A.S.E. Ojugo, P.M.J. Mesheehy, D.J.O. McIntyre, C. McCoy, M. Stubbs, M.O. Leach, I.R. Judson, and J.R. Griffiths Measurement of the extracellular pH of solid tumors in mice by magnetic resonance spectroscopy: a comparison of exogenous 19F and 31P probes NMR Biomed. 12 1999 495 504 (Pubitemid 30090160)
26. J.S. Park, T.H. Han, K.Y. Lee, S.S. Han, J.J. Hwang, D.H. Moon, S.Y. Kim, and Y.W. Cho N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: endocytosis, exocytosis and drug release J. Control. Release 115 2006 37 45 (Pubitemid 44415079)
27. Y. Park, E. Kang, O.J. Kwon, H.K. Park, J.H. Kim, and C.O. Yun Tumor targeted adenovirus nanocomplex ionically crosslinked by chitosan J. Control. Release 148 2010 e124
28. C. Riganti, C. Voena, J. Kopecka, P.A. Corsetto, G. Montorfano, E. Enrico, C. Costamagna, A.M. Rizzo, D. Ghigo, and A. Bosia Liposome-encapsulated doxorubicin reverses drug resistance by inhibiting P-glycoprotein in human cancer cells Mol. Pharm. 8 3 2011 683 700
29. S. Rodrigues, M. Dionísio, C.R. López, and A. Grenha Biocompatibility of chitosan carriers with application in drug delivery J. Funct. Biomater. 3 2012 615 641
30. S.K. Sahu, S.K. Mallick, S. Santra, T.K. Maiti, S.K. Ghosh, and P. Pramatik In vitro evaluation of folic acid modified carboxymethyl chitosan nanoparticles loaded with doxorubicin for targeted delivery J. Mater. Sci. - Mater. Med. 21 2010 1587 1597
31. X.Z. Shu, and K.J. Zhu The influence of multivalent phosphate structure on the properties of ionically cross-linked chitosan films for controlled drug release Eur. J. Pharm. Biopharm. 54 2002 235 243 (Pubitemid 34919399)
32. K. Strebhardt, and A. Ullrich Paul Ehrlich's magic bullet concept: 100 years of progress Nat. Rev. Cancer 8 2008 473 480 (Pubitemid 351752547)
33. C. Sun, J.S.H. Lee, and M.Q. Zhang Magnetic nanoparticles in MR imaging and drug delivery Adv. Drug Deliv. Rev. 60 2008 1252 1265
34. M.L. Tan, P.F.M. Choong, and C.R. Dass Review: doxorubicin delivery systems based on chitosan for cancer therapy J. Pharm. Pharmacol. 61 2009 131 142
35. W. Tiyaboanchai, and N. Limpeanchob Formulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticles Int. J. Pharm. 329 2007 142 149 (Pubitemid 44937518)
36. G. Unsoy, S. Yalcin, R. Khodadust, G. Gunduz, and U. Gunduz Synthesis optimization and characterization of chitosan-coated iron oxide nanoparticles produced for biomedical applications J. Nanopart. Res. 14 2012 964 968
37. R.S. Van, Z.M. Bhujwalla, P. Ballerteros, J. Alverez, S. Cerdan, J.P. Galons, and R.J. Gillies In vivo imaging of extracellular pH using 1H MSRI Magn. Reson. Med. 41 1999 743 750 (Pubitemid 29205721)
38. J. Wood Doxorubicin M. Allwood, The Cytotoxics Handbook fourth ed. 2002 Radcliffe Medical Press Oxford 322 329
39. Q. Yuan, J. Shah, S. Hein, and R.D. Misra Controlled and extended drug release behavior of chitosan-based nanoparticle carrier Acta Biomater. 6 2010 1140 1148
40. X. Zeng, M. Ralf, and M.N. Andreas Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-mediated drug resistance" Biomaterials 35 4 2014 1227 1239